Echinaceainduction of phase II enzymes
First Claim
1. A method of inducing the expression of a phase II enzyme in a mammal comprising administering to the mammal a therapeutically effective amount of a a chloroform-soluble Echinacea purpurea fraction selected from the group consisting of a chloroform root fraction, an acidic chloroform aerial fraction, and a combination thereof.
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to the use of Echinacea as a cancer chemopreventive agent to block the formation of and to detoxify cancer-causing agents, or carcinogens. More particularly, the present invention relates to the induction of phase II enzymes by Echinacea, and specifically by lipid-soluble fractions isolated from Echinacea. The present invention also contemplates a novel method of extracting the desired lipid-soluble fractions from Echinacea.
65 Citations
3 Claims
- 1. A method of inducing the expression of a phase II enzyme in a mammal comprising administering to the mammal a therapeutically effective amount of a a chloroform-soluble Echinacea purpurea fraction selected from the group consisting of a chloroform root fraction, an acidic chloroform aerial fraction, and a combination thereof.
Specification
-
- Resources
-
Current AssigneeAccess Business Group International LLC (Alticor Incorporated)
-
Original AssigneeAccess Business Group International LLC (Alticor Incorporated)
-
InventorsQian, Yong, Truax, Kari L., David, Puri G., Li, Yingqin, Brovelli, Ernesto A.
-
Primary Examiner(s)MELLER, MICHAEL V
-
Application NumberUS09/575,307Time in Patent Office2,083 DaysField of Search424/737, 424/773, 424/725US Class Current424/725CPC Class CodesA61K 36/28 Asteraceae or Compositae (A...
